Innovation Pharmaceuticals Inc (IPIX)

[Ahrdee]

You can find one of the posters presented on the phase II study on Brilacidin here:poster

The adverse events data is at the top right.
One effect that is clearly associated with the compound is "tingling and numbness."
The systolic pressure rise is probably more critical but this might be overcome with switch to the low dosage which was quite effective.
However, this raises the prospect that even if Brilacidin will meet efficacy standards, it might come with warning labels.

The drug it is being compared with looks much better on these fronts. This could have been part of the reason for investor disenchantment.

For what it is worth.
I as an investor like to know what I am getting. Life is seldom packaged with just moonlight and roses, but also bad breath and whatnot.

Best to all.